Trillium Therapeutics

Trillium is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, focusing on CD47 programs and SIRPα-Fc fusion proteins

trilliumtherapeutics.com

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Trillium is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, focusing on CD47 programs and SIRPα-Fc fusion proteins.

02Backed By1 investor

FLFrazier Life Sciences→

03Similar Companies